Zepbound leads to more weight loss than Wegovy, Eli Lilly says
Zepbound, a drug with the main active ingredient tirzepatide, was found to be more helpful in helping people lose weight than Wegovy, a drug with the main active ingredient semaglutide, according to new data released Wednesday by Eli Lilly, the maker of Zepbound.
While President-elect Donald Trump looks poised to scrap many policies of the Biden administration, one veteran analyst says ...
Leptin by itself doesn't hold promise for weight loss — but a new mouse study suggests it could work in combination with ...
13hOpinion
Ozempic and Wegovy might be making it harder for physicians to guide patients toward lifestyle changes − the real key to long ...
Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound. Here's how we reported it.
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback